Burn therapy--a current appraisal.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000818:Animals; D002056:Burns / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D004381:Duodenal Ulcer / Q000209:etiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007223:Infant; D059408:Pain Management; D010952:Plasma Substitutes / Q000627:therapeutic use; D011552:Pseudomonas Infections / Q000517:prevention & control; D012774:Shock, Traumatic / Q000209:etiology / Q000628:therapy; D012835:Silver Nitrate / Q000627:therapeutic use; D016038:Skin Transplantation; D013411:Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D013552:Swine; D013577:Syndrome; D013923:Thromboembolism / Q000209:etiology; D013924:Thrombophlebitis / Q000209:etiology; D014140:Tracheotomy; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014945:Wound Healing; D014946:Wound Infection / Q000517:prevention & control
D005839:Gentamicins; D010952:Plasma Substitutes; D013449:Sulfonamides; D013411:Sulfadiazine; D012835:Silver Nitrate